These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

322 related items for PubMed ID: 15312350

  • 1. [Prognostic value of expression of FASE, HER-2/neu, bcl-2 and p53 in stage I non-small cell lung cancer].
    Wang Y, Zhang XR, Fu J, Tan W, Zhang W.
    Zhonghua Zhong Liu Za Zhi; 2004 Jun; 26(6):369-72. PubMed ID: 15312350
    [Abstract] [Full Text] [Related]

  • 2. Evaluation of P-glycoprotein, HER-2/ErbB-2, p53, and Bcl-2 in primary tumor and metachronous lung metastases in patients with high-grade osteosarcoma.
    Ferrari S, Bertoni F, Zanella L, Setola E, Bacchini P, Alberghini M, Versari M, Bacci G.
    Cancer; 2004 May 01; 100(9):1936-42. PubMed ID: 15112275
    [Abstract] [Full Text] [Related]

  • 3. A prognostic model of recurrence and death in stage I non-small cell lung cancer utilizing presentation, histopathology, and oncoprotein expression.
    Harpole DH, Herndon JE, Wolfe WG, Iglehart JD, Marks JR.
    Cancer Res; 1995 Jan 01; 55(1):51-6. PubMed ID: 7805040
    [Abstract] [Full Text] [Related]

  • 4. [Study of prognostic factors in patients with stage I non-small cell lung cancer].
    Jiang ZQ, Jiang GL, Shi DR, Zhang RX, Fu XL, Qian H.
    Zhonghua Zhong Liu Za Zhi; 2004 Jun 01; 26(6):364-8. PubMed ID: 15312349
    [Abstract] [Full Text] [Related]

  • 5. Study of pretreatment serum levels of HER-2/neu oncoprotein as a prognostic and predictive factor in patients with advanced nonsmall cell lung carcinoma.
    Ardizzoni A, Cafferata MA, Paganuzzi M, Filiberti R, Marroni P, Neri M, Fontana V, Nicoló G, Perdelli L, Stampino CG, Rosso R, Puntoni R.
    Cancer; 2001 Oct 01; 92(7):1896-904. PubMed ID: 11745263
    [Abstract] [Full Text] [Related]

  • 6. Vascular endothelial growth factor, p53, Rb, Bcl-2 expression and response to chemotherapy in advanced non-small cell lung cancer.
    Ludovini V, Gregorc V, Pistola L, Mihaylova Z, Floriani I, Darwish S, Stracci F, Tofanetti FR, Ferraldeschi M, Di Carlo L, Ragusa M, Daddi G, Tonato M.
    Lung Cancer; 2004 Oct 01; 46(1):77-85. PubMed ID: 15364135
    [Abstract] [Full Text] [Related]

  • 7. Multivariate analysis of bcl-2, apoptosis, P53 and HER-2/neu in breast cancer: a short-term follow-up.
    el-Ahmady O, el-Salahy E, Mahmoud M, Wahab MA, Eissa S, Khalifa A.
    Anticancer Res; 2002 Oct 01; 22(4):2493-9. PubMed ID: 12174951
    [Abstract] [Full Text] [Related]

  • 8. Combined expression of p53, Bcl-2, and p21WAF-1 proteins in lung cancer and premalignant lesions: association with clinical characteristics.
    Kalomenidis I, Orphanidou D, Papamichalis G, Vassilakopoulos T, Scorilas A, Rasidakis A, Papastamatiou H, Jordanoglou J, Roussos C.
    Lung; 2001 Oct 01; 179(5):265-78. PubMed ID: 11976895
    [Abstract] [Full Text] [Related]

  • 9. Bcl-2 protein expression correlates with better prognosis in patients with advanced non-small cell lung cancer.
    Shibata Y, Hidaka S, Tagawa Y, Nagayasu T.
    Anticancer Res; 2004 Oct 01; 24(3b):1925-8. PubMed ID: 15274378
    [Abstract] [Full Text] [Related]

  • 10. Skip metastasis in nonsmall cell lung carcinoma: predictive markers and isolated tumor cells in N1 lymph nodes.
    Prenzel KL, Baldus SE, Mönig SP, Tack D, Sinning JM, Gutschow CA, Grass G, Schneider PM, Dienes HP, Hölscher AH.
    Cancer; 2004 May 01; 100(9):1909-17. PubMed ID: 15112272
    [Abstract] [Full Text] [Related]

  • 11. Expression of apoptosis regulatory proteins of the Bcl-2 family and p53 in primary resected non-small-cell lung cancer.
    Borner MM, Brousset P, Pfanner-Meyer B, Bacchi M, Vonlanthen S, Hotz MA, Altermatt HJ, Schlaifer D, Reed JC, Betticher DC.
    Br J Cancer; 1999 Feb 01; 79(5-6):952-8. PubMed ID: 10070896
    [Abstract] [Full Text] [Related]

  • 12. Localized adenocarcinoma of the lung: oncogene expression of erbB-2 and p53 in 150 patients.
    Harpole DH, Marks JR, Richards WG, Herndon JE, Sugarbaker DJ.
    Clin Cancer Res; 1995 Jun 01; 1(6):659-64. PubMed ID: 9816029
    [Abstract] [Full Text] [Related]

  • 13. Prognostic value of immunohistochemical expressions of p53, HER-2/neu, and bcl-2 in stage I non-small-cell lung cancer.
    Han H, Landreneau RJ, Santucci TS, Tung MY, Macherey RS, Shackney SE, Sturgis CD, Raab SS, Silverman JF.
    Hum Pathol; 2002 Jan 01; 33(1):105-10. PubMed ID: 11823980
    [Abstract] [Full Text] [Related]

  • 14. Tumor expression of S100A6 correlates with survival of patients with stage I non-small-cell lung cancer.
    De Petris L, Orre LM, Kanter L, Pernemalm M, Koyi H, Lewensohn R, Lehtiö J.
    Lung Cancer; 2009 Mar 01; 63(3):410-7. PubMed ID: 18620780
    [Abstract] [Full Text] [Related]

  • 15. p53 and P-glycoprotein expression do not correlate with survival in nonsmall cell lung cancer: a long-term study and literature review.
    Haque AK, Adegboyega P, Al-Salameh A, Vrazel DP, Zwischenberger J.
    Mod Pathol; 1999 Dec 01; 12(12):1158-66. PubMed ID: 10619270
    [Abstract] [Full Text] [Related]

  • 16. [Significance of fatty acid synthase expression in non-small cell lung cancer].
    Wang Y, Zhang X, Tan W, Fu J, Zhang W.
    Zhonghua Zhong Liu Za Zhi; 2002 May 01; 24(3):271-3. PubMed ID: 12515624
    [Abstract] [Full Text] [Related]

  • 17. Bax protein expression in colorectal cancer: association with p53, bcl-2 and patterns of relapse.
    Giatromanolaki A, Sivridis E, Stathopoulos GP, Fountzilas G, Kalofonos HP, Tsamandas A, Vrettou E, Scopa C, Polychronidis A, Simopoulos K, Koukourakis MI.
    Anticancer Res; 2001 May 01; 21(1A):253-9. PubMed ID: 11299743
    [Abstract] [Full Text] [Related]

  • 18. Evaluation of different markers in non-small cell lung cancer: prognostic value of clinical staging, tumour cell detection and tumour marker analysis for tumour progression and overall survival.
    Kasimir-Bauer S, Schleucher N, Weber R, Neumann R, Seeber S.
    Oncol Rep; 2003 May 01; 10(2):475-82. PubMed ID: 12579292
    [Abstract] [Full Text] [Related]

  • 19. [Correlation analysis among expression of ERCC-1, metallothionein, p53 and platinum resistance and prognosis in advanced non-small cell lung cancer].
    Huang PY, Liang XM, Lin SX, Luo RZ, Hou JH, Zhang L.
    Ai Zheng; 2004 Jul 01; 23(7):845-50. PubMed ID: 15248926
    [Abstract] [Full Text] [Related]

  • 20. HER-2/neu oncogene and estrogen receptor expression in non small cell lung cancer patients.
    Alerić I, Razumović JJ, Koprivica B.
    Med Pregl; 2012 Jul 01; 65(5-6):210-5. PubMed ID: 22730705
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.